FindTrial
Sign In

Cohort study of different initial therapy and conversion therapy for chronic obstructive pulmonary disease

Cohort study of different initial therapy and conversion therapy for chronic obstructive pulmonary disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058229
Enrollment
Unknown
Registered
2022-04-03
Start date
2022-07-01
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

Group 1 :
Group 2:

Sponsors

The Second Affiliated Hospital of Kunming Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. In accordance with the diagnostic criteria of the Guidelines for the Diagnosis and Treatment of COPD formulated by the Respiratory Branch of the Chinese Medical Association (2018 Revised Edition); 2. Clear consciousness, no obstruction of phlegm, can breathe autonomously.

Exclusion criteria

Exclusion criteria: 1. Severe dysfunction of heart, liver and kidney organs; 2. Patients with bronchial asthma, severe bronchiectasis, digestive tract diseases, active tuberculosis, diabetes, hyperthyroidism, malignant tumors and other wasting diseases.

Design outcomes

Primary

MeasureTime frame
lung function;Modified Medical Research Council (mMRC) Dyspnea Scale;COPD assessment test;Baseline Dyspnea Index, BDI;COPD clinical questionnaire;St George's respiratory questionnaire;6 min walking distance;—

Countries

China

Contacts

Public ContactLi Yongxia

The Second Affiliated Hospital of Kunming Medical University

liyongxia0720@126.com+86 13658810805

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026